131 related articles for article (PubMed ID: 19251299)
1. Mapping of suramin binding sites on the group IIA human secreted phospholipase A2.
Vieira DS; Aragão EA; Lourenzoni MR; Ward RJ
Bioorg Chem; 2009 Apr; 37(2):41-5. PubMed ID: 19251299
[TBL] [Abstract][Full Text] [Related]
2. Suramin inhibits macrophage activation by human group IIA phospholipase A2, but does not affect bactericidal activity of the enzyme.
Aragão EA; Chioato L; Ferreira TL; de Medeiros AI; Secatto A; Faccioli LH; Ward RJ
Inflamm Res; 2009 Apr; 58(4):210-7. PubMed ID: 19169647
[TBL] [Abstract][Full Text] [Related]
3. Characterization of suramin binding sites on the human group IIA secreted phospholipase A2 by site-directed mutagenesis and molecular dynamics simulation.
Aragão EA; Vieira DS; Chioato L; Ferreira TL; Lourenzoni MR; Silva SR; Ward RJ
Arch Biochem Biophys; 2012 Mar; 519(1):17-22. PubMed ID: 22248627
[TBL] [Abstract][Full Text] [Related]
4. Mapping the suramin-binding sites of human neutrophil elastase: investigation by fluorescence resonance energy transfer and molecular modeling.
Mély Y; Cadène M; Sylte I; Bieth JG
Biochemistry; 1997 Dec; 36(50):15624-31. PubMed ID: 9398290
[TBL] [Abstract][Full Text] [Related]
5. Catalytic and non-catalytic functions of human IIA phospholipase A2.
Birts CN; Barton CH; Wilton DC
Trends Biochem Sci; 2010 Jan; 35(1):28-35. PubMed ID: 19818633
[TBL] [Abstract][Full Text] [Related]
6. Suramin interaction with human alpha-thrombin: inhibitory effects and binding studies.
Monteiro RQ; Campana PT; Melo PA; Bianconi ML
Int J Biochem Cell Biol; 2004 Oct; 36(10):2077-85. PubMed ID: 15203120
[TBL] [Abstract][Full Text] [Related]
7. Secretory phospholipase A2 activity toward diverse substrates.
Madsen JJ; Linderoth L; Subramanian AK; Andresen TL; Peters GH
J Phys Chem B; 2011 Jun; 115(21):6853-61. PubMed ID: 21561115
[TBL] [Abstract][Full Text] [Related]
8. Understanding the mechanism of the antimitogenic activity of suramin.
Kathir KM; Kumar TK; Yu C
Biochemistry; 2006 Jan; 45(3):899-906. PubMed ID: 16411766
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulations reveal structural insights into inhibitor binding modes and functionality in human Group IIA phospholipase A
Kim RR; Malde AK; Nematollahi A; Scott KF; Church WB
Proteins; 2017 May; 85(5):827-842. PubMed ID: 28056488
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin.
Murakami MT; Arruda EZ; Melo PA; Martinez AB; Calil-Eliás S; Tomaz MA; Lomonte B; Gutiérrez JM; Arni RK
J Mol Biol; 2005 Jul; 350(3):416-26. PubMed ID: 15961104
[TBL] [Abstract][Full Text] [Related]
11. Structural characterization of myotoxic ecarpholin S from Echis carinatus venom.
Zhou X; Tan TC; Valiyaveettil S; Go ML; Kini RM; Velazquez-Campoy A; Sivaraman J
Biophys J; 2008 Oct; 95(7):3366-80. PubMed ID: 18586854
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
[TBL] [Abstract][Full Text] [Related]
13. Thermodynamic characterization of cytosolic phospholipase A2 alpha inhibitors.
Ramarao MK; Shen MW; Murphy EA; Duan W; Zhao Y; McKew J; Lee KL; Thakker P; Behnke ML; Clark JD
Anal Biochem; 2008 Dec; 383(2):217-25. PubMed ID: 18801329
[TBL] [Abstract][Full Text] [Related]
14. The NMR solution structure of human epidermal growth factor (hEGF) at physiological pH and its interactions with suramin.
Huang HW; Mohan SK; Yu C
Biochem Biophys Res Commun; 2010 Nov; 402(4):705-10. PubMed ID: 21029725
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin.
Schuetz A; Min J; Antoshenko T; Wang CL; Allali-Hassani A; Dong A; Loppnau P; Vedadi M; Bochkarev A; Sternglanz R; Plotnikov AN
Structure; 2007 Mar; 15(3):377-89. PubMed ID: 17355872
[TBL] [Abstract][Full Text] [Related]
16. The molecular mechanism of human group IIA phospholipase A2 inactivation by bolinaquinone.
Monti MC; Chini MG; Margarucci L; Tosco A; Riccio R; Bifulco G; Casapullo A
J Mol Recognit; 2009; 22(6):530-7. PubMed ID: 19621421
[TBL] [Abstract][Full Text] [Related]
17. Quinoline-4-methyl esters as human nonpancreatic secretory phospholipase A₂ inhibitors.
Wu Y; Chen Z; Liu Y; Yu L; Zhou L; Yang S; Lai L
Bioorg Med Chem; 2011 Jun; 19(11):3361-6. PubMed ID: 21555224
[TBL] [Abstract][Full Text] [Related]
18. Application of isothermal titration calorimetry and column chromatography for identification of biomolecular targets.
Zhou X; Kini RM; Sivaraman J
Nat Protoc; 2011 Feb; 6(2):158-65. PubMed ID: 21293457
[TBL] [Abstract][Full Text] [Related]
19. Understanding binding affinity: a combined isothermal titration calorimetry/molecular dynamics study of the binding of a series of hydrophobically modified benzamidinium chloride inhibitors to trypsin.
Talhout R; Villa A; Mark AE; Engberts JB
J Am Chem Soc; 2003 Sep; 125(35):10570-9. PubMed ID: 12940739
[TBL] [Abstract][Full Text] [Related]
20. Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
Vasilakaki S; Barbayianni E; Leonis G; Papadopoulos MG; Mavromoustakos T; Gelb MH; Kokotos G
Bioorg Med Chem; 2016 Apr; 24(8):1683-95. PubMed ID: 26970660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
